Ontology highlight
ABSTRACT: Background
Plasma markers of neuronal injury in Creutzfeldt-Jakob disease (CJD) are established, but peripheral biomarkers reflecting glial activation, synaptic dysfunction, and vascular impairment remain less explored. We systematically assessed these markers in symptomatic CJD and asymptomatic PRNP mutation carriers to improve diagnosis and identify early pathophysiology.Methods
This prospective cohort study recruited CJD, frontotemporal dementia (FTD), healthy controls (HCs), and preclinical familial CJD pedigrees. Sixteen plasma proteins representing neuronal injury, glial activation, synaptic function, and vascular/BBB integrity were measured. Analyses included group differences, discriminative performance, clinical/imaging correlations, and longitudinal trajectories.<
SUBMITTER: Chen ZY
PROVIDER: S-EPMC12828275 | biostudies-literature | 2026 Jan
REPOSITORIES: biostudies-literature